A novel biomarker for gut leakage as a diagnostic tool for HIV disease progression

Investigating a novel plasma biomarker's potential for identifying gut leakage.

Accelerating ART initiation among Infants (AAMI Study)

This project will trial the POC VISITECT® CD4 test and POC LYNX HIV p24 early infant diagnostic test.

Access to affordable and accurate HIV-1 VL testing

Laboratory evaluation of a novel filter paper-based method of plasma separation for viral load testing.

Access to CD4 (VISITECT® CD4) testing among HIV-infected women in Kenya

An accessible CD4 (VISITECT® CD4) test for HIV-infected pregnant and postpartum women in Kenya.

ACCESS: STI and BBV surveillance system

ACCESS is a surveillance system that collates important information on a range of STIs and BBVs.

Broadly neutralising anti-HIV antibodies and Fc Receptor function

Defining the properties of anti-HIV antibodies for vaccine development and protection of pregnant women.

co-EC Study: Eliminating hepatitis C/HIV coinfection

Eliminating hepatitis C transmission by enhancing care and treatment among HIV co-infected individuals.

Community-Based Rapid HIV Testing Services

Evaluating a multi-site rapid HIV testing trial in South Australia and rural site in Bendigo, Victoria.

DARE C: ATAHC II Substudy

DARE-C aims to evaluate therapy duration using triple therapy (PEG-IFN/RBV/TPV).

Developing new HIV disease progression tests

This project will develop prognostic tools to identify HIV+ persons at risk of rapid disease progression.

Development of a novel prophylactic vaccine candidate for HIV-1

A prophylactic vaccine represents the best strategy for blocking HIV-1 transmission.

Harm reduction among People who Inject Drugs in Myanmar

Aims to prevent the transmission of HIV among young people, students, migrant and transport workers.

HIV Clinical Training for Doctors

HIV Clinical Training for doctors in urban and rural locations in resource constrained countries.

HIV Prevention Cohort

Online cohort study of gay men in Victoria monitoring community-level change.

HIV testing among young men who have sex with men in Myanmar

Examining factors associated with HIV testing uptake among young men who have sex with men in Myanmar.

Optima HIV: maximising the impact of HIV funding

Developing and applying software to maximise the impact of HIV funding around the world.

Plasma separator device for HIV viral load testing

Aimed at improving access to HIV viral load assays in resource-limited settings.

PrEPX: Rapid scale-up of HIV pre-exposure prophylaxis (PrEP)

Burnet is playing a crucial role in monitoring the outcomes of the PrEPX trial in Victoria.

PRONTO! Rapid HIV point-of-care testing in Victoria

The first rapid HIV test service in Victoria targeting gay men and men who have sex with men.

TAIPAN: HIV cascade surveillance

Internationally novel project to create a linked surveillance system to monitor the HIV cascade for gay men

The Victorian Primary Care Network for Sentinel Surveillance on BBVs and STIs

The surveillance involves collection and linking of testing, demographic, and risk behaviour information.

VISITECT® CD4 point-of-care test

An affordable HIV point-of-care test developed by Burnet but licensed to Omega Diagnostics.